Search results
Report on H5N1 in Cattle, Cats Increases Concern of Spillover Event
MedPage Today· 6 days agoCows infected with H5N1 avian influenza had mild illness characterized by a drop in milk production,...
Obesity drug rivals aim to unseat Zepbound, Ozempic - Indianapolis Business Journal
Indianapolis Business Journal· 3 days agoInsatiable demand for weight-loss drugs has made the market so feverish that any positive mention of...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoNew York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli
Amgen investors await weight-loss drug data
AOL· 5 days agoAmgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We are still collecting and analyzing the ...
AI may help diagnose rare diseases years earlier
UPI· 3 days agoA newly developed AI program was able to successfully identify people at risk of developing a rare immune disorder, researchers report. Artificial...
How to Maximize Carrots
Mercola· 4 days agoThere are astonishing arrays of vegetables in the world of every shape and color, each representing an amazing commodity. It's incredible that you can put seeds in the ground, give them adequate ...
Charles River Laboratories International (NYSE:CRL) versus OneMedNet (NASDAQ:ONMD) Head to Head...
ETF DAILY NEWS· 3 days agoCharles River Laboratories International (NYSE:CRL – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both medical companies, but which is the better stock? We will contrast ...
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
AOL· 2 days agoRespiratory virus season may be ending in the United States, but a new group of COVID-19 variants are circulating, sparking concerns about a potential summer wave. The family of variants, nicknamed ...
Here are the obesity drug hopefuls vying to unseat Ozempic, Zepbound
San Francisco Chronicle· 3 days agoInsatiable demand for weight-loss drugs has made the market so feverish that any positive mention of a potential obesity therapy can send a company’s stock surging - even if those treatments ...
Machine learning tool identifies rare, undiagnosed immune disorders through patients’ electronic...
Newswise· 5 days agoResearchers say a machine learning tool can identify many patients with rare, undiagnosed diseases years earlier, potentially improving outcomes and reducing cost and morbidity. The findings ...